Profile
Ole Wiborg is the founder of Wiborg ApS.
Prior to founding Wiborg ApS, he worked as the Director of Project Development & Licensing at Takeda AS.
He also served as the Chief Operating Officer at Topotarget A for a brief period in 2002.
Additionally, he worked as the Chief Business Officer at Prophylix AS.
Mr. Wiborg received his undergraduate and graduate degrees from the University of Copenhagen.
Former positions of Ole Wiborg
| Companies | Position | End |
|---|---|---|
| TOPOTARGET A/S | Chief Operating Officer | 2001-12-31 |
Takeda AS
 Takeda AS Pharmaceuticals: MajorHealth Technology Takeda AS operates as a pharmaceutical company. It manufactures and distributes generic medicines. The firm offers therapeutics in the areas such as cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. The company founded by Morten Nyegaard in 1874 and is headquartered in Asker, Norway. | Corporate Officer/Principal | - |
| Wiborg ApS | Founder | - |
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Corporate Officer/Principal | - |
Training of Ole Wiborg
| University of Copenhagen | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Takeda AS
Takeda AS Pharmaceuticals: MajorHealth Technology Takeda AS operates as a pharmaceutical company. It manufactures and distributes generic medicines. The firm offers therapeutics in the areas such as cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. The company founded by Morten Nyegaard in 1874 and is headquartered in Asker, Norway. | Health Technology |
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
| Wiborg ApS |
- Stock Market
- Insiders
- Ole Wiborg
